Completed
Health literacy—the degree to which individuals can access, comprehend, and use information to make health care decisions—is a critical skill that enables people to engage in healthy behaviors to reduce cancer risk and improve health outcomes across the continuum of cancer care. The National Cancer Policy Forum and the Roundtable on Health Literacy convened a workshop to examine opportunities to improve communication in cancer care and to better support people across a range of health literacy abilities.
Featured publication
Workshop
·2020
Health literacy is a critical skill for engaging in healthy behaviors to reduce disease risk and improve health outcomes across the continuum of cancer care. However, estimates suggest that more than one-third of the U.S. adult population has low health literacy, and nearly half of all patients with...
View details
Description
A planning committee will plan and host a 1.5-day public workshop that will examine opportunities, methods, and strategies to improve the communication of information about cancer care at the level of the clinic visit, the health care organization, and the community. The workshop will feature invited presentations and panel discussions on topics that may include:
- Strategies and best practices for health care professionals to improve the communication of evidence-based information regarding cancer risk, prevention, detection, or treatment to patients and their families.
- Effective communication strategies to build trust and counter inaccurate information about cancer, especially given the evolving nature of the evidence base and the increasing complexity of cancer care.
- Opportunities to tailor messaging strategies and information about cancer to meet the needs of diverse populations.
- Procedures, policies, and programs at the organizational level to assess and consistently address the diverse health literacy needs of patients and their families.
The planning committee will develop the agenda for the workshop sessions, select and invite speakers and discussants, and moderate the discussions. A proceedings of the presentations and discussions at the workshop will be prepared by a designated rapporteur in accordance with institutional guidelines.
Collaborators
Committee
Karen Basen-Engquist
Co-Chair
Michael Paasche-Orlow
Co-Chair
Garnet L. Anderson
Member
Edward J. Benz, Jr.
Member
Linda Bohannon
Member
Nicole F. Dowling
Member
Christine Gunn
Member
Lori Hoffman Hogg
Member
Ashley Housten
Member
Beth Y. Karlan
Member
Lisa Kennedy-Sheldon
Member
Cathy D. Meade
Member
Randall A. Oyer
Member
Robert A. Winn
Member
Robin Yabroff
Member
Sponsors
American Association for Cancer Research
American Cancer Society
American College of Radiology
American Society of Clinical Oncology
Association of American Cancer Institutes
Association of Community Cancer Centers
Bristol Myers Squibb
Cancer Support Community
Centers for Disease Control and Prevention (CDC)
CEO Roundtable on Cancer
Flatiron Health
Helsinn Therapeutics (U.S.), Inc.
Merck
National Comprehensive Cancer Network
National Institutes of Health/National Cancer Institute
National Patient Advocate Foundation
Novartis Oncology
Oncology Nursing Society
Pfizer Inc.
Society for Immunotherapy of Cancer
Staff
Sharyl Nass
Lead
Erin Balogh
Lead
Emily Zevon
Ruth Cooper